Trendlines sets up JV in Shanghai
THE Trendlines Group on Monday announced that it has together with Chinese private equity firm Shoushan Wealth Holdings, set up China-Israel New Trend (Taizhou) Medical Technology.
The latter, which will be based in Shanghai, is a joint venture to help Trendlines' medical sector portfolio companies as well as other Israeli, Singaporean and other medical companies penetrate the Chinese market.
This includes helping companies establish manufacturing capabilities in China, obtain regulatory approval for the sale of products in China, and manage strategic partner relationships.
Trendlines and Shoushan also intend to raise venture funds (in US dollar and Chinese renminbi) to invest in global medical technology companies.
Trendlines is a Catalist-listed, Israeli and Singapore-based incubator that invests in and nurtures early-stage medical and agricultural technology companies.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Meituan to debut in Riyadh as expansion beyond China quickens
Mapletree Industrial Trust to distribute S$13 million of divestment gains over next 4 quarters
K-pop agency Hybe’s internal strife wipes out 1.2 trillion won
Beijing city to subsidise domestic AI chips, targets self-reliance by 2027
Hong Kong bourse regains favour on hopes of a market revival
Chinese sellers go to TikTok school to reach buyers abroad